Last checked: 11 September 2026. Scope: personal medicines when relocating to Australia, the UK, New Zealand or Canada. Rules depend on the medicine, traveller’s status, route and arrival date.
Your prescription may help a medicine pass the border without allowing the next pharmacy to refill it. For a move, the useful question is not simply how much medicine fits in your luggage. It is: when will your next lawful supply actually be in your hands?
This guide separates border permission from local prescribing and physical supply, then provides a medicine-by-medicine calculation. It does not recommend treatments or changes to prescribed doses.
A date-sensitive Canadian change: the enacted Controlled Substances Regulations take effect on 1 October 2026. Do not apply their new traveller allowance to a September arrival. The current and forthcoming rules are separated below. Source: Canada Gazette, sections 225 and 239.
Three separate permissions—not one prescription
Border permission: can this person bring this exact ingredient, formulation and quantity through this route? Check the departure country, destination and applicable transit rules. A medicine’s familiar brand name is not a substitute for identifying its ingredients. The CDC’s restricted-medication guidance explains why a medicine acceptable at home can create problems elsewhere, including during a layover.
Prescribing permission: can a local pharmacist accept the prescription, or must a locally authorised clinician first assess you? A letter proving that a medicine belongs to you is not automatically an order a foreign pharmacy can dispense.
Actual supply: after any necessary assessment, can the pharmacy obtain the required medicine before your carried supply runs out? Ask about the exact strength and formulation, not merely whether the country has pharmacies.
Payment is another question. Our public-healthcare start-date guide deals with coverage and funding. Here, the focus is continuity of medicine: a payer, a prescriber and a supply need to line up.
Start with the right rule for what you are carrying
| Destination and route | Starting-point allowance | Crucial qualification |
|---|---|---|
| Australia: traveller exemption | Up to 3 months | Eligible personal medicines; postal imports use a different pathway |
| UK: specified controlled medicines | Up to 3 months for Schedule 2–4 Part I medicines under the personal-import policy | Not a universal limit for every prescription medicine or every returning resident |
| New Zealand: carried medicines | Ordinary prescriptions: 3 months; controlled drugs: 1 month | Oral contraceptives have a 6-month exception |
| Canada: eligible visitors, ordinary prescriptions | 90 days or one treatment course, whichever is less | Resident and controlled-substance rules differ |
| Canada: narcotics and controlled drugs, through 30 September 2026 | 30 days or one treatment course, whichever is less | Targeted substances have separate rules |
| Canada: qualifying medicines under the new regulations, from 1 October 2026 | Up to 90 days | Schedules 1–3 only; traveller, declaration and labelling conditions apply |
Official sources and exceptions are linked in each country section below. Three months is not automatically exactly 90 days, and one month is not automatically exactly 30 days. Preserve the authority’s wording when confirming your quantity. A destination’s ceiling also does not oblige your existing prescriber, pharmacy or insurer to provide that much in advance.
Australia: a medicine in your bag is not the same as a parcel
The TGA’s traveller guidance allows many medicines under its traveller exemption, with original packaging and a prescription or doctor’s letter, for yourself or immediate family travelling with you. The Office of Drug Control explains the additional controlled-medicine conditions. Check the actual ingredient rather than assuming every controlled medicine is either prohibited or freely permitted.
For medicines arriving by mail or courier, the Personal Importation Scheme, updated on 8 September 2026, requires a valid Australian prescription or written authority at the time of import if the product is prescription-only in Australia. The usual limit is 3 months per import, with no more than 15 months’ supply imported in a 12-month period. That annual ceiling is not permission to order 15 months at once. Controlled substances are excluded from this scheme.
The TGA also says electronic prescriptions cannot serve as valid written authority for importation. Do not confuse this with their use at Australian pharmacies. Obtaining the required authority only after a parcel is held does not satisfy the import condition.
The TGA’s 8 September packaging announcement reinforces the need for identifiable packaging and labels. The practical conclusion: ask about the local prescription and lawful supply route before counting an overseas parcel as your backup.
UK: the three-month controlled-drug policy has boundaries
The Home Office’s personal-import policy covers specified medicines lawfully prescribed and dispensed to visitors in their country of habitual residence. Temporary residents staying longer should arrange further supplies through a UK clinician. Controlled medicines cannot simply be posted to the patient from abroad.
Two exceptions deserve attention. Someone habitually resident in the UK who receives controlled medicines during treatment abroad must contact the Home Office before returning; the same personal-import policy does not apply. Schedule 1 drugs require a licence and cannot be treated as an ordinary travel allowance. For medicines without controlled ingredients, consult MHRA requirements rather than borrowing the controlled-drug limit.
The government’s traveller checklist calls for proof that controlled medicine is yours and carrying it in hand luggage. Arrange the clinician’s letter before departure, with the medicine, dose, strength, quantity and travel information required for your circumstances.
New Zealand: one medicine can have a much shorter runway
New Zealand Customs requires original packaging and a prescription copy or doctor’s letter. All controlled drugs must be declared on the New Zealand Traveller Declaration. Its guidance also requires declaration of ordinary prescription medicines when carrying more than 3 months or when they are not prescribed to you or a family member. Declaring an item does not itself authorise an otherwise excessive or prohibited import; when uncertain, ask before travelling and declare on arrival.
For eligible prescription medicines sent from overseas, Medsafe requires an original prescription or letter from a New Zealand-authorised prescriber. It must identify the matching medicine, strength, form and quantity and show that the prescriber knowingly authorises overseas importation. Controlled drugs cannot be imported through this personal postal route.
For planning, calculate each medicine separately. A longer allowance for one product does not solve the shorter allowance for another. Start the local-care enquiry with the medicine whose continuity is hardest to arrange—not the easiest repeat prescription on the list.
Canada: check both your status and your arrival date
Health Canada’s personal-use guidance distinguishes visitors from residents. Visitor evidence can include study or work documentation. Eligible visitors staying over 3 months can receive an additional personal 90-day supply every 3 months by mail or courier, but this is not permission to bypass controlled-substance restrictions.
Canadian residents generally cannot personally import foreign prescription medicines, although limited exceptions may be permitted—for example, returning with medicine prescribed and dispensed in Canada, continuing treatment that had to begin abroad, or recently landed immigrants continuing treatment. Confirm the applicable exception; do not assume permanent immigration gives you every visitor privilege.
For entry through 30 September 2026
The current controlled-medication guidance requires narcotics and controlled drugs to be prescribed, labelled, in pharmacy or hospital packaging, and declared. They cannot be mailed into Canada.
Do not apply that category’s 30-day ceiling to every targeted substance, such as certain benzodiazepines. A foreign resident’s targeted-substance limit is the smallest of a full container, 90 days, or the amount needed for the stay. A Canadian resident’s limit is one treatment course or 90 days, whichever is less. Other prescription, packaging and declaration conditions still apply.
For entry from 1 October 2026
Section 225 of the new Controlled Substances Regulations provides a traveller route for substances in its Schedules 1–3, covering narcotics, controlled drugs and targeted substances. The medicine must be in the traveller’s possession or baggage and declared. Required labelling identifies the patient and authorising provider, medicine, form, strength, quantity and daily dose; the 90-day ceiling is based on that authorised dose.
This is not a postal-refill authorisation, does not extend to Schedule 4 restricted drugs, and does not override another country’s departure or transit law. Reconfirm the applicable requirements close to travel, especially around the changeover. Cannabis and CBD products need separate product-specific checks; this comparison is not permission to carry them.
Calculate the Better Places Medication Bridge Clock
Once the lawful route is established, replace the headline allowance with your actual usable supply. Our planning calculation is:
Medication Bridge Clock = usable supply remaining on arrival − time until the next lawful supply is actually available.
Call the first number S and the second T, both measured in days. Then test an additional delay allowance, B:
Stress-tested headroom = S − T − B.
S is not the maximum you read on a government page. It is what you can lawfully carry and use after accounting for medicine taken before arrival, expiry and storage requirements. Have your pharmacist confirm the count against your existing prescribed schedule. As-needed, variable-dose and closely monitored treatments need an individual plan, not simple daily arithmetic.
T ends at dispensing, not at the first appointment. Include the actual sequence of registration, records review, any required specialist assessment, prescribing and pharmacy sourcing. Add sequential delays, but do not double-count tasks that run in parallel. A booked appointment is not a promise that a clinician will prescribe a particular medicine.
B is a stress test, not a medical safety standard. Agree an appropriate contingency with your treating professionals. It does not authorise carrying extra medicine above a legal allowance. If a necessary step has no credible date, write “unconfirmed”; entering zero creates false confidence.
Three scenarios that produce different decisions
The following numbers are hypothetical planning inputs, not observed waiting times, national averages or recommended medicine quantities. Each assumes the stated arrival supply has independently been confirmed as lawful and usable. Seven days is used only to demonstrate the arithmetic.
| Scenario | Assumed supply and refill timeline | Result |
|---|---|---|
| A: straightforward local assessment | S = 90 days. First appointment after 14 days; dispensing 5 days later. T = 19. | Clock: 90 − 19 = 71 days. After B = 7: 64 days. |
| B: early appointment, later specialist decision | S = 30 days. First appointment after 10 days; additional review takes 21 days; dispensing takes 4 more. T = 35. | Clock: 30 − 35 = −5 days. After B = 7: −12 days. |
| C: the pharmacy sourcing delay matters | S = 60 days. Assessment after 7 days; obtaining the medicine takes 28 more. T = 35. | Clock: 60 − 35 = 25 days. After B = 7: 18 days. |
Scenario B fails even though the first appointment is relatively early: the assumed supply ends five days before the refill. Adding a seven-day stress test exposes a twelve-day planning deficit; it does not mean twelve days without treatment is acceptable.
The response is to resolve the care pathway before departure: establish whether records and referrals can be assessed earlier, confirm another lawful arrangement with the treating team, or reconsider the move date. Do not bridge the gap by rationing, stopping, sharing or substituting medicine yourself.
For a household, take the smallest headroom across all necessary medicines and people—not the average. A partner’s spare supply is not yours to use. One unresolved medicine can determine the practical readiness of the whole move.
Find out whether your foreign prescription can actually be used
It is too broad to say that foreign prescriptions never work. For example, UK guidance permits certain prescriptions from approved EEA and Swiss prescribers to be dispensed privately, subject to the required checks and the pharmacist’s judgement. That route does not permit dispensing Schedule 1–3 controlled drugs or unlicensed “specials”. Recognition, clinical suitability, availability and public reimbursement remain different questions.
Before fixing a move date, send a prospective registered practice an enquiry like this. Use its secure channel for medical records rather than a public form or comment:
I am relocating on [date] and need an assessment for continuity of an existing prescribed medicine. Can your practice assess this treatment, and what records, referral or specialist review would be required? What is the earliest assessment date? Which parts of the prescribing process cannot be confirmed until I am seen?
Separately ask a registered pharmacy about the exact ingredient, strength and dosage form, whether a locally valid prescription is required, and likely sourcing time after that prescription is received. Obtain actual consultation and medicine prices, including the position before any subsidy or insurance reimbursement. An appointment quote is not a complete refill quote.
Keep one handover record for every medicine
The CDC recommends carrying medical information and medicine details, including generic names. Build on that with a short relocation record rather than a folder of unrelated screenshots:
- Identity and permission: exact ingredient, strength and formulation; each relevant authority’s rule; permitted quantity; required declaration, letter or approval; date checked.
- Usable stock: pharmacist-confirmed amount expected on arrival and when it runs out under the existing prescribed schedule. Record storage constraints separately.
- Next supply: receiving clinician, records required, assessment date, remaining steps and pharmacy contact. Mark estimated and confirmed dates differently.
- Contingency: whom to contact if an appointment, approval or shipment fails; the treating team’s instructions; and money available for the agreed lawful route.
Keep the record private. Its purpose is to make a handover workable, not to publish your health history. Recheck it if the flight, prescription, route, formulation or immigration status changes.
Pack for evidence, access and storage—not just suitcase space
The CDC advises original labelled containers and carry-on luggage, with prescription copies and appropriate documentation for medical supplies. Keep labels readable; do not replace border evidence with an unlabelled pill organiser.
For temperature-sensitive medicines, ask your pharmacist how the actual itinerary—including airport waits and the journey to your new home—can meet the product’s storage requirements. Confirm airline and security arrangements for liquids, needles and cooling equipment separately from import permission. Ask the treating team about dosing across time zones; this guide does not calculate or alter doses.
The Better Places decision
If legality is unresolved, do not pack on the assumption that a prescription fixes it. If importation is lawful but your refill date is unknown or the headroom is negative, the continuity plan remains incomplete. Positive arithmetic is useful, but it is not clinical clearance or a guarantee against disruption.
The move is better prepared when each medicine has a documented lawful entry route, a credible path to the next actual supply and a clinician-agreed contingency—not merely when the luggage contains the published maximum.
For the wider destination decision, place this record alongside our visa, healthcare and real-cost checklist.
Method and limitations: official sources were checked on 11 September 2026. The Canadian October rules are enacted but not yet in force on that checking date. The bridge calculations are original Better Places planning scenarios, not clinical predictions or measured service times. This is general relocation information, not individual medical or legal advice. Confirm your medicine and route with the responsible authorities, prescriber and pharmacist. Seek prompt professional help if continuity is threatened; do not wait for paperwork in a medical emergency.
Featured photograph by Jens Riesenberg on Unsplash. The suitcase is an editorial travel illustration, not an example of how to pack medicines.
Leave a Reply